P. Londborg

发表

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.

B. Rothbaum, M. Hegel, J. Davidson, 2001, The American journal of psychiatry.

Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxiety.

G. Tollefson, P. Londborg, W. Smith, 1999, Journal of clinical psychopharmacology.

blind, placebo-controlled, fixed-dose investigation Sertraline in the treatment of panic disorder. A multi-site, double-

E. Duboff, Ward T. Smith, R. Wolkow, 2011 .

P-2-37 Double-blind comparison of three fixed doses of sertraline and placebo in patients with panic disorder

E. Duboff, R. Wolkow, J. Ferguson, 1995, European Neuropsychopharmacology.

Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.

Norma Pugh, P. Murali Doraiswamy, Madhukar H. Trivedi, 2002, JAMA.

Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment.

M. Hegel, R. Maddock, J. Himmelhoch, 2001, The Journal of clinical psychiatry.

Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

J. Davidson, C. Janney, D. Zimbroff, 2003, The American journal of psychiatry.

Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression.

J. R. Painter, Ward T. Smith, P. Londborg, 2000, Journal of affective disorders.

Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?

J. R. Painter, Ward T. Smith, P. Londborg, 2002, Journal of affective disorders.

Interruption of selective serotonin reuptake inhibitor treatment

J. Amsterdam, M. Fava, R. Tamura, 2000, British Journal of Psychiatry.

Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment

J. Amsterdam, M. Fava, R. Tamura, 2000, Psychoneuroendocrinology.

Zolpidem for persistent insomnia in SSRI-treated depressed patients.

A. Krystal, R. Rosenberg, G. Asnis, 1999, The Journal of clinical psychiatry.

Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study

M. Fava, L. Baer, G. Papakostas, 2010, International clinical psychopharmacology.

Gepirone extended-release in the treatment of adult outpatients with major depressive disorder: a double-blind, randomized, placebo-controlled, parallel-group study.

K. Weiss, Ward T. Smith, J. Horrigan, 2008, The Journal of clinical psychiatry.

Efficacy of Sertraline in Preventing Relapse of Posttraumatic Stress Disorder

B. Rothbaum, M. Hegel, J. Davidson, 2003 .

Sertraline and posttraumatic stress disorder: Results of 24 weeks of open-label sertraline followed by a 28-week discontinuation study

B. Rothbaum, J. Davidson, G. Farfel, 2000, European Neuropsychopharmacology.

Sertraline in the treatment of panic disorder

E. Duboff, J. Ferguson, Ward T. Smith, 1998, British Journal of Psychiatry.

Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.

M. Liebowitz, C. Clary, K. Weihs, 2003, The Journal of clinical psychiatry.

Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study.

J. R. Painter, Ward T. Smith, P. Londborg, 1998, The American journal of psychiatry.

The efficacy of sertraline in panic disorder: combined results from two fixed‐dose studies

C. Clary, J. Sheikh, R. Fayyad, 2000, International clinical psychopharmacology.